References
- Ogawa R. Keloid and hypertrophic scars are the result of chronic inflammation in the reticular dermis. IJMS. 2017;18(3):606.
- Jones ME, McLane J, Adenegan R, et al. Advancing keloid treatment: a novel multimodal approach to ear keloids. Dermatol Surg. 2017;43(9):1164–1169.
- Lee JY, Yang CC, Chao SC, Wong TW. Histopathological differential diagnosis of keloid and hypertrophic scar. Am J Dermatopathol. 2004;26(5):379–384.
- LaRanger R, Karimpour-Fard A, Costa C, et al. Analysis of keloid response to 5-Fluorouracil treatment and long-term prevention of keloid recurrence. Plast Reconstr Surg. 2019;143(2):490–494.
- Mrowietz U, Seifert O. Keloid scarring: new treatments ahead. Actas Dermosifiliogr. 2009;100 Suppl 2 (Suppl 2):75–83.
- Ekstein SF, Wyles SP, Moran SL, et al. Keloids: a review of therapeutic management. Int J Dermatol. 2021;60(6):661–671.
- Atiyeh BS, Costagliola M, Hayek SN. Keloid or hypertrophic scar: the controversy: review of the literature. Ann Plast Surg. 2005;54(6):676–680.
- Hsu KC, Luan CW, Tsai YW. Review of silicone gel sheeting and silicone gel for the prevention of hypertrophic scars and keloids. Wounds. 2017;29(5):154–158.
- Tan S, Khumalo N, Bayat A. Understanding keloid pathobiology from a quasi-neoplastic perspective: less of a scar and more of a chronic inflammatory disease with cancer-like tendencies. Front Immunol. 2019;10:1810.
- He Y, Deng Z, Alghamdi M, et al. From genetics to epigenetics: new insights into keloid scarring. Cell Prolif. 2017;50(2):e12326.
- Andrews JP, Marttala J, Macarak E, et al. Keloids: the paradigm of skin fibrosis –pathomechanisms and treatment. Matrix Biol. 2016;51:37–46.
- Jumper N, Paus R, Bayat A. Functional histopathology of keloid disease. Histol Histopathol. 2015;30(9):1033–1057.
- König IR, Fuchs O, Hansen G, et al. What is precision medicine? Eur Respir J. 2017;50(4):1700391.
- Lee HJ, Jang YJ. Recent understandings of biology, prophylaxis and treatment strategies for hypertrophic scars and keloids. IJMS. 2018;19(3):711.
- Wang ZC, Zhao WY, Cao Y, et al. The roles of inflammation in keloid and hypertrophic scars. Front Immunol. 2020;11:603187.
- Qin Y, Li L, Luo E, et al. Role of m6A RNA methylation in cardiovascular disease (review). Int J Mol Med. 2020;46(6):1958–1972.
- Fang Y, Tian S, Pan Y, et al. Pyroptosis: a new frontier in cancer. Biomed Pharmacother. 2020;121:109595.
- Frank D, Vince JE. Pyroptosis versus necroptosis: similarities, differences, and crosstalk. Cell Death Differ. 2019;26(1):99–114.
- Shi J, Gao W, Shao F. Pyroptosis: gasdermin-mediated programmed necrotic cell death. Trends Biochem Sci. 2017;42(4):245–254.
- Kovacs SB, Miao EA. Gasdermins: effectors of pyroptosis. Trends Cell Biol. 2017;27(9):673–684.
- Huang C, Liu L, You Z, et al. Managing keloid scars: from radiation therapy to actual and potential drug deliveries. Int Wound J. 2019;16(3):852–859.